Diosmetin overcomes resistance to cisplatin in ovarian cancer by suppressing the MAPK signaling pathway. - Nie J; Jiang H; Zhou R; Gong R; Xu W; Zhang P; Lu L; Lyu L (Medical oncology (Northwood, London, England), 2026)